MedWand®'s Latest Regulatory Green Light Enables Use of the Sensor Based Medical Device for Comprehensive Patient Assessment Internationally
Nyenta.com/10268738

RANCHO SANTA MARGARITA, Calif. - Nyenta -- MedWand Solutions, Inc., the ultimate healthcare solution and a pioneer in telehealth technology, is pleased to announce its recent regulatory clearance in Thailand. This latest approval allows MedWand to empower a broader spectrum of clinicians and healthcare providers, enabling them to elevate care standards and grant easier access to healthcare services.

"The regulatory clearance in Thailand reflects our dedication to making comprehensive remote healthcare services accessible worldwide," shared MedWand Senior Director of International Business Development, Stuart English. "We are thrilled to bring MedWand to Thailand, addressing healthcare needs and creating new opportunities for collaboration with international partners."

More on Nyenta.com

• Rochester: City Launches Community-Wide Survey on the Impact of the Opioid Epidemic
• New Rochelle: December Events!
• Invenio IT Expands Cybersecurity Offerings with Datto Antivirus (AV)
• Long Island Company Offers Heated Restroom Trailers for Winter Events
• The WIT (Women in Technology) Network Appoints Cheryl Stookes as Strategic Advisor

MedWand is the ultimate healthcare solution, seamlessly integrating traditional tools and Bluetooth connectivity for vitals capture and remote patient evaluations to enhance efficiency, convenience, and access to care. Following its FDA clearance and product launch in the United States in 2022, MedWand has gained significant traction with major US health systems, telehealth companies, large private practices, and employers.

"Following thorough research, we have identified the MedWand multi-sensor vitals capture device, together with the VirtualCare telemedicine platform, as the pivotal components essential for revolutionizing telemedicine services. This combination is poised to facilitate advanced clinical care accessible to patients regardless of their location, eliminating the necessity for hospital visits," commented Dr. Supornchai Kongpatanakul, President of Kitmeechai Trading Co., Ltd.

The device's versatility and ease of use make it a valuable asset for both healthcare professionals and patients. Transforming the traditional understanding of telehealth, MedWand combines multiple vitals sensors into one, handheld, lightweight device. Data collected can include core temperature, blood oxygen saturation, and pulse rate, heart, lung and abdominal auscultations, electrocardiogram*, and high definition otoscopic, oropharynx, and dermatoscopic exam images. Through approved 3rd party Bluetooth peripherals, MedWand can also seamlessly capture blood pressure, glucometer, spirometry, and weight data.

More on Nyenta.com

• "Federal Complaint Filed: David Medeiros Uncovers Medicaid Mismanagement, ADA Violations, and Systemic Failures in Connecticut"
• Strata Credit Union Selects Scienaptic's AI-Powered Credit Underwriting Platform
• CD&R Appoints Andy Callahan, Former CEO of Hostess Brands, as Operating Advisor
• Introducing Feelness: A Revolutionary Solution for Physical Self-Care Without the Fitness Lifestyle
• Omnitronics Wins Software Combined 2024 AI Innovation Award

For more information on MedWand visit www.medwand.com. To schedule a private demonstration or to request a formal quotation please contact MedWand at https://www.medwandhealth.com/contact.

*Electrocardiogram feature is currently awaiting US FDA 510(k) clearance.